Fluoxetine effects on mitochondrial ultrastructure of right ventricle in rats exposed to cold stress

Rev Bras Cir Cardiovasc. 2009 Apr-Jun;24(2):173-9. doi: 10.1590/s0102-76382009000200013.

Abstract

Objective: To assess fluoxetine effects on mitochondrial structure of the right ventricle in rats exposed to cold stress.

Methods: The experimental study procedures were performed in 250-300g male EPM-Wistar rats. Rats (n=40) were divided into four groups: 1) Control group (CON); 2) Fluoxetine (FLU); 3) Induced hypothermia (IH) and; 4) Induced hypothermia treated with fluoxetine (IHF). Animals of FLU group were treated by the administration of gavages containing 0.75 mg/kg/day fluoxetine during 40 days. The induced hypothermia was obtained by maintaining the groups 3 and 4 in a freezer at -8 degrees C for 4 hours. The animals were sacrificed and fragments of the right ventricle (RV) were removed and processed prior to performing electron microscopic analysis.

Results: The ultrastructural changes in cardiomyocytes were quantified through the number of mitochondrial cristae pattern (cristolysis). The CON (3.85%), FLU (4.47%) and IHF (8.4%) groups showed a normal cellular structure aspect with preserved cardiomyocytes cytoarchitecture and continuous sarcoplasmic membrane integrity. On the other hand, the IH (34.4%) group showed mitochondrial edema and lysis in cristae.

Conclusion: The ultrastructural analysis revealed that fluoxetine strongly prevents mitochondrial cristolysis in rat heart, suggesting a protector effect under cold stress condition.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cold Temperature
  • Fluoxetine / pharmacology*
  • Heart Ventricles / drug effects
  • Heart Ventricles / ultrastructure
  • Hypothermia, Induced*
  • Male
  • Mitochondria, Heart / drug effects*
  • Mitochondria, Heart / ultrastructure
  • Models, Animal
  • Myocytes, Cardiac / drug effects*
  • Myocytes, Cardiac / ultrastructure
  • Protective Agents / pharmacology*
  • Rats
  • Rats, Wistar

Substances

  • Protective Agents
  • Fluoxetine